Gulf International Bank UK Ltd trimmed its position in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 55.8% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 32,290 shares of the real estate investment trust's stock after selling 40,713 shares during the period. Gulf International Bank UK Ltd's holdings in Healthpeak Properties were worth $652,000 as of its most recent SEC filing.
Several other hedge funds also recently added to or reduced their stakes in DOC. Nuveen LLC bought a new position in Healthpeak Properties during the 1st quarter valued at about $124,113,000. Resolution Capital Ltd bought a new position in Healthpeak Properties in the 4th quarter worth about $122,795,000. Invesco Ltd. grew its stake in Healthpeak Properties by 20.7% in the 1st quarter. Invesco Ltd. now owns 23,111,320 shares of the real estate investment trust's stock worth $467,311,000 after acquiring an additional 3,967,830 shares in the last quarter. Northern Trust Corp grew its stake in Healthpeak Properties by 32.6% in the 4th quarter. Northern Trust Corp now owns 10,526,223 shares of the real estate investment trust's stock worth $213,367,000 after acquiring an additional 2,590,530 shares in the last quarter. Finally, Centersquare Investment Management LLC grew its stake in Healthpeak Properties by 18.5% in the 1st quarter. Centersquare Investment Management LLC now owns 13,285,932 shares of the real estate investment trust's stock worth $268,642,000 after acquiring an additional 2,070,416 shares in the last quarter. 93.57% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
DOC has been the topic of a number of research analyst reports. Wells Fargo & Company dropped their target price on shares of Healthpeak Properties from $22.00 to $20.00 and set an "equal weight" rating on the stock in a research note on Monday, June 2nd. Deutsche Bank Aktiengesellschaft restated a "hold" rating and issued a $18.00 target price (down from $28.00) on shares of Healthpeak Properties in a research note on Wednesday. Wall Street Zen downgraded shares of Healthpeak Properties from a "hold" rating to a "sell" rating in a research note on Monday, July 7th. Scotiabank downgraded shares of Healthpeak Properties from a "sector outperform" rating to a "sector perform" rating and dropped their target price for the stock from $21.00 to $19.00 in a research note on Tuesday, July 29th. Finally, Robert W. Baird set a $21.00 target price on shares of Healthpeak Properties and gave the stock an "outperform" rating in a research note on Wednesday, July 30th. Seven equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $22.10.
Check Out Our Latest Research Report on DOC
Insider Activity at Healthpeak Properties
In other news, Director Tommy G. Thompson bought 5,777 shares of the stock in a transaction on Wednesday, May 28th. The stock was bought at an average cost of $17.27 per share, for a total transaction of $99,768.79. Following the completion of the purchase, the director directly owned 144,290 shares in the company, valued at approximately $2,491,888.30. The trade was a 4.17% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Scott M. Brinker purchased 1,490 shares of the firm's stock in a transaction on Monday, August 4th. The stock was bought at an average cost of $16.83 per share, with a total value of $25,076.70. Following the acquisition, the chief executive officer owned 211,906 shares of the company's stock, valued at approximately $3,566,377.98. The trade was a 0.71% increase in their position. The disclosure for this purchase can be found here. Over the last 90 days, insiders acquired 14,560 shares of company stock valued at $249,898. 0.23% of the stock is owned by insiders.
Healthpeak Properties Stock Up 3.0%
Shares of NYSE DOC traded up $0.5250 during midday trading on Friday, reaching $17.8050. 2,180,971 shares of the company's stock traded hands, compared to its average volume of 6,041,156. The company has a quick ratio of 1.28, a current ratio of 1.28 and a debt-to-equity ratio of 1.06. The stock's 50 day simple moving average is $17.61 and its 200-day simple moving average is $18.40. Healthpeak Properties, Inc. has a one year low of $16.63 and a one year high of $23.26. The company has a market cap of $12.37 billion, a price-to-earnings ratio of 74.15, a P/E/G ratio of 2.20 and a beta of 1.05.
Healthpeak Properties (NYSE:DOC - Get Free Report) last released its quarterly earnings data on Thursday, July 24th. The real estate investment trust reported $0.46 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.46. Healthpeak Properties had a net margin of 5.90% and a return on equity of 1.85%. The firm had revenue of $694.35 million for the quarter, compared to the consensus estimate of $697.14 million. During the same period last year, the firm earned $0.45 earnings per share. The company's quarterly revenue was down .2% on a year-over-year basis. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. On average, analysts predict that Healthpeak Properties, Inc. will post 1.86 EPS for the current fiscal year.
Healthpeak Properties Dividend Announcement
The company also recently announced a dividend, which will be paid on Friday, August 29th. Shareholders of record on Tuesday, August 19th will be paid a $0.1017 dividend. This represents a yield of 705.0%. The ex-dividend date is Monday, August 18th. Healthpeak Properties's dividend payout ratio (DPR) is 508.33%.
About Healthpeak Properties
(
Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Featured Stories

Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report